Tampere – Finland’s Most Desirable City to Live in – Attracts Tech Talent From Europe
10.8.2023 21:46:00 EEST | Business Wire | Press release
Nestled in the world's happiest country, Tampere, a forward-thinking city, look towards Europe for skilled tech professionals and startup entrepreneurs. Tampere’s International House is hosting an online hackathon-style recruitment event, titled Game On!, on 14–15 September. As part of the hackathon, Tampere is inviting 12 applicants to experience the true Tampere lifestyle.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230810179331/en/
Tampere has a strong tech community and active ecosystems for example in machine learning, imaging, mobile and manufacturing technologies. (Photo: Business Wire)
Tampere is a city known for its courage to grow and go forward. Located in the heart of Finland, Tampere is home to blooming tech companies such as Valmet, Treon, and Colossal Order. Unlike the tech industry in many crowded cities, these tech companies can offer their employees an escape from the chaos and a lifestyle with affordable, easy-access housing and a high standard of living.
Tampere has a strong tech community and active ecosystems for example in machine learning, imaging, mobile and manufacturing technologies. The growing city and its tech industry need bright new tech minds. In the Experience Tampere campaign, European professionals are especially targeted.
Twelve of the tech professionals and startup founders who register for the event by 16 August also have a chance to win a five-day immersive experience in Tampere. There will be a versatile programme for both talents and startup owners coming to experience the hidden gem of Finland between the 12th and 16th of September.
"It will be a unique experience and an opportunity for the winners to meet the companies, get to know the city, its tech scene, and the lifestyle. Tampere will show that high tech can be combined with a vibrant community and chill sauna evenings by beautiful lakeside scenery," says Sini Vilppula, Vice President, Human Resources, at Automation System Business Line in Valmet.
For startup founders, the city organizes a programme where they get to explore the Startup Tampere ecosystem, visit co-working spaces, innovation centers, and accelerators, and feel the energy of the Platform 6 Startup House. Furthermore, connect with local startups, network with founders, gain insights from industry experts, and create new possibilities for their startups.
All participants get to experience Finnish culture with their families and discover the unique charm of Tampere, enjoy cultural activities, indulge in traditional Finnish cuisine, and build connections beyond business.
Further information:
Experience Tampere - International House Tampere
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230810179331/en/
Contact information
Marketing Specialist
Tiia Heikkilä
tiia.heikkila@tampere.fi
+358 41 730 2921
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom